Amolyt Pharma
Divya Gupta has several years of experience in the regulatory affairs field. Divya is currently working as a Senior Manager of Regulatory Strategy at Amolyt Pharma, a position they started in April 2022. Prior to this, Divya worked at bluebird bio as a Manager of Regulatory Strategy from December 2020 to April 2022. Divya also worked at Vascular Dynamics as a Senior Specialist of Regulatory Affairs from May 2019 to December 2020, and at MicroVention-Terumo as a Specialist of Regulatory Affairs from June 2017 to May 2019.
Divya Gupta has a Bachelor's degree in Physiology from the University of Minnesota-Twin Cities. Divya also holds a Master's degree in Regulatory Affairs & Quality Assurance from Temple University School of Pharmacy.
This person is not in any offices
Amolyt Pharma
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.